09 Sep 2021 --- Ahead of an over US$8 million investment in a production facility, Kirin Holdings is unveiling food products containing Lactococcus lactis strain Plasma to target immunity demands in Japan. The company notes that 70 percent of consumers interested in immune products have yet to try them.
